메뉴 건너뛰기




Volumn 30, Issue 4, 2007, Pages 295-300

Improvement of blood pressure control in hypertensive patients with renal diseases

Author keywords

Angiotensin II receptor blockers; Blood pressure control; New guidelines; Physicians' awareness; Renal diseases

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

EID: 34249056172     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.295     Document Type: Article
Times cited : (2)

References (27)
  • 1
    • 34248997600 scopus 로고    scopus 로고
    • Executive summary
    • Executive summary. Am J Kidney Dis 2004; 43: S16-S41.
    • (2004) Am J Kidney Dis , vol.43
  • 2
    • 0030034592 scopus 로고    scopus 로고
    • Blood pressure and end-stage renal disease in men
    • Klag MJ, Whelton PK, Randall BL, et al: Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18.
    • (1996) N Engl J Med , vol.334 , pp. 13-18
    • Klag, M.J.1    Whelton, P.K.2    Randall, B.L.3
  • 3
    • 0036841387 scopus 로고    scopus 로고
    • Is it the agent or the blood pressure level that matters for renal protection in chronic nephropathies?
    • Locatelli F, Vecchio LD, D'amico M, Andrulli S: Is it the agent or the blood pressure level that matters for renal protection in chronic nephropathies? J Am Soc Nephrol 2002; 13: S196-S201.
    • (2002) J Am Soc Nephrol , vol.13
    • Locatelli, F.1    Vecchio, L.D.2    D'amico, M.3    Andrulli, S.4
  • 4
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • Hansson L, Zanchetti A, Carruthers SG, et al: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762.
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3
  • 5
    • 0028838569 scopus 로고
    • Blood pressure control, proteinuria and the progression of renal diseases. The modification of diet in renal disease study
    • Peterson JC, Adler S, Burkart JM, et al: Blood pressure control, proteinuria and the progression of renal diseases. The modification of diet in renal disease study. Ann Intern Med 1995; 123: 754-762.
    • (1995) Ann Intern Med , vol.123 , pp. 754-762
    • Peterson, J.C.1    Adler, S.2    Burkart, J.M.3
  • 6
    • 0026481126 scopus 로고
    • Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects
    • for the MRFIT Research Group
    • Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD, for the MRFIT Research Group: Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. JAMA 1992; 268: 3085-3091.
    • (1992) JAMA , vol.268 , pp. 3085-3091
    • Walker, W.G.1    Neaton, J.D.2    Cutler, J.A.3    Neuwirth, R.4    Cohen, J.D.5
  • 7
    • 0032511580 scopus 로고    scopus 로고
    • Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
    • UK Prospective Diabetes Study Group
    • UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
    • (1998) BMJ , vol.317 , pp. 703-713
  • 8
    • 0033069767 scopus 로고    scopus 로고
    • World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
    • Guidelines Subcommittee
    • Guidelines Subcommittee: 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151-183.
    • (1999) J Hypertens , vol.1999 , Issue.17 , pp. 151-183
  • 9
    • 0030713021 scopus 로고    scopus 로고
    • Detection, Evaluation, and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    • Joint National Committee on Prevention
    • Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
    • (1997) Arch Intern Med , vol.157 , pp. 2413-2446
  • 10
    • 0347423198 scopus 로고    scopus 로고
    • Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    • Chobanian AV, Bakris GL, Black HR, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
    • (2003) Hypertension , vol.42 , pp. 1206-1252
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3
  • 11
    • 0344718782 scopus 로고    scopus 로고
    • World Health Organization (WHO) International Society of Hypertension (ISH) statement on management of hypertension
    • World Health Organization, International Society of Hypertension Writing Group
    • World Health Organization, International Society of Hypertension Writing Group: 2003 World Health Organization (WHO) International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983-1992.
    • (2003) J Hypertens , vol.2003 , Issue.21 , pp. 1983-1992
  • 12
    • 0041810638 scopus 로고    scopus 로고
    • The role of arterial hypertension in the progression of non-diabetic glomerular diseases
    • Ljutić D, Kes P: The role of arterial hypertension in the progression of non-diabetic glomerular diseases. Nephrol Dial Transplant 2003; 18: S28-S30.
    • (2003) Nephrol Dial Transplant , vol.18
    • Ljutić, D.1    Kes, P.2
  • 13
    • 3242891578 scopus 로고    scopus 로고
    • Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases
    • Kojima S, Shida M, Yokoyama H: Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases. Hypertens Res 2004; 27: 379-385.
    • (2004) Hypertens Res , vol.27 , pp. 379-385
    • Kojima, S.1    Shida, M.2    Yokoyama, H.3
  • 14
    • 0035816018 scopus 로고    scopus 로고
    • Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis. A randomized controlled trial
    • Agodoa L, Appel L, Bakris G, et al: Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis. A randomized controlled trial. JAMA 2001; 285: 2719-2728.
    • (2001) JAMA , vol.285 , pp. 2719-2728
    • Agodoa, L.1    Appel, L.2    Bakris, G.3
  • 15
    • 0037031270 scopus 로고    scopus 로고
    • Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus. A blood pressure-independent effect
    • for the Microalbuminuria Reduction with Valsartan (MARVAL) Study Investigators
    • Viberti G, Wheeldon NM, for the Microalbuminuria Reduction with Valsartan (MARVAL) Study Investigators: Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus. A blood pressure-independent effect. Circulation 2002; 106: 672-678.
    • (2002) Circulation , vol.106 , pp. 672-678
    • Viberti, G.1    Wheeldon, N.M.2
  • 16
    • 0030668490 scopus 로고    scopus 로고
    • Efficacy and tolerability of valsartan compared with lisinopril in patients with hypertension and renal insufficiency
    • Perico N, Spormann D, Peruzzi E, Bodin F, Sioufi A, Bertocchi F: Efficacy and tolerability of valsartan compared with lisinopril in patients with hypertension and renal insufficiency. Clin Drug Invest 1997; 14: 252-259.
    • (1997) Clin Drug Invest , vol.14 , pp. 252-259
    • Perico, N.1    Spormann, D.2    Peruzzi, E.3    Bodin, F.4    Sioufi, A.5    Bertocchi, F.6
  • 17
    • 0035922441 scopus 로고    scopus 로고
    • Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    • Brenner BM, Cooper ME, Zeeuw D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
    • (2001) N Engl J Med , vol.345 , pp. 861-869
    • Brenner, B.M.1    Cooper, M.E.2    Zeeuw, D.3
  • 18
    • 0037145856 scopus 로고    scopus 로고
    • Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. Results from the AASK Trial
    • Wright JT, Bakris G, Greene T, et al: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. Results from the AASK Trial. JAMA 2002; 288: 2421-2431.
    • (2002) JAMA , vol.288 , pp. 2421-2431
    • Wright, J.T.1    Bakris, G.2    Greene, T.3
  • 19
    • 0345516005 scopus 로고    scopus 로고
    • Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension
    • Plum J, Bünten B, Németh R, Grabensee B: Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension. J Am Soc Nephrol 1998; 9: 2223-2234.
    • (1998) J Am Soc Nephrol , vol.9 , pp. 2223-2234
    • Plum, J.1    Bünten, B.2    Németh, R.3    Grabensee, B.4
  • 20
    • 0037378751 scopus 로고    scopus 로고
    • Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy
    • Jacobsen P, Andersen S, Jensen BR, Parving HH: Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy. J Am Soc Nephrol 2003; 14: 992-999.
    • (2003) J Am Soc Nephrol , vol.14 , pp. 992-999
    • Jacobsen, P.1    Andersen, S.2    Jensen, B.R.3    Parving, H.H.4
  • 21
    • 0037363248 scopus 로고    scopus 로고
    • Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses
    • Segura J, Praga M, Campo C, Rodicio JL, Ruilope LM: Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses. JRAAS 2003; 4: 43-47.
    • (2003) JRAAS , vol.4 , pp. 43-47
    • Segura, J.1    Praga, M.2    Campo, C.3    Rodicio, J.L.4    Ruilope, L.M.5
  • 22
    • 0642373661 scopus 로고    scopus 로고
    • How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: According to blood pressure or proteinuria?
    • Segura J, Christiansen H, Campo C, Ruilope LM: How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria? Curr Hypertens Rep 2003; 5: 426-429.
    • (2003) Curr Hypertens Rep , vol.5 , pp. 426-429
    • Segura, J.1    Christiansen, H.2    Campo, C.3    Ruilope, L.M.4
  • 23
    • 11244253140 scopus 로고    scopus 로고
    • Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency
    • Giri S, Mahajan SK, Sen R, Sharma A: Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency. J Assoc Physicians India 2002; 50: 1245-1250.
    • (2002) J Assoc Physicians India , vol.50 , pp. 1245-1250
    • Giri, S.1    Mahajan, S.K.2    Sen, R.3    Sharma, A.4
  • 24
    • 10744223299 scopus 로고    scopus 로고
    • Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies
    • Campbell R, Sangalli F, Perticucci E, et al: Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney Int 2003: 63 1094-1103.
    • (2003) Kidney Int , vol.63 , pp. 1094-1103
    • Campbell, R.1    Sangalli, F.2    Perticucci, E.3
  • 25
    • 0345530947 scopus 로고    scopus 로고
    • Differing anti-proteinuric action of candesartan and losartan in chronic renal disease
    • Matsuda H, Hayashi K, Homma K, et al: Differing anti-proteinuric action of candesartan and losartan in chronic renal disease. Hypertens Res 2003; 26: 875-880. 1
    • (2003) Hypertens Res , vol.26 , Issue.875-880 , pp. 1
    • Matsuda, H.1    Hayashi, K.2    Homma, K.3
  • 26
    • 1642502319 scopus 로고    scopus 로고
    • National Kidney Foundation practice guideline for chronic kidney disease, evaluation, classification, and stratification
    • Levey AS, Coresh J, Balk E, et al: National Kidney Foundation practice guideline for chronic kidney disease, evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-149.
    • (2003) Ann Intern Med , vol.139 , pp. 137-149
    • Levey, A.S.1    Coresh, J.2    Balk, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.